Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02678442 · ClinicalTrials.gov registry record · NA
Endoscopic Ultrasound Guided Fine Needle Biopsy (EUS-FNB-SC) Using a Novel Fork Needle
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT02678442: Completed NA study, sponsored by Mayo Clinic.
NCT02678442 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02678442, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
This is a clinical trial to compare two needles used in biopsy techniques to acquire tissue from pancreatic cancer. The hypothesis is that the tissue yield, as measured by tumor DNA and cellular material is superior for Flexible Needle Biopsy (FNB) compared with conventional Fine Needle Aspiration (FNA). Specifically, FNB will increase the proportion of cases in which sufficient DNA is obtained to allow genomic profiling and whole exome sequencing.
Interventions
- DEVICE Fine Needle Biopsy (FNB)
- DEVICE Fine Needle Aspiration (FNA)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2016-05-16 |
| Est. Completion | 2018-11-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02678442
The ClinicalTrials.gov registry entry for NCT02678442 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Fine Needle Biopsy (FNB) is the first listed.
NCT02678442 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02678442 about?
NCT02678442 is a clinical study titled "Endoscopic Ultrasound Guided Fine Needle Biopsy (EUS-FNB-SC) Using a Novel Fork Needle". This is a clinical trial to compare two needles used in biopsy techniques to acquire tissue from pancreatic cancer. The hypothesis is that the tissue yield, as measured by tumor DNA and cellular material is superior for Flexible Needle Biopsy (FNB) compared with conventional Fine Needle Aspiration (...
What is the current status of trial NCT02678442?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2016-05-16. Estimated completion is 2018-11-10.
What interventions are being tested in trial NCT02678442?
The interventions under investigation include: Fine Needle Biopsy (FNB) (DEVICE), Fine Needle Aspiration (FNA) (DEVICE).
Who is sponsoring clinical trial NCT02678442?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.